Susquehanna International Group
CERE

Susquehanna International Group’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Susquehanna International Group’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-108,832
Closed -$4.45M – 13387
2024
Q2 		$4.45M Sell
108,832
-4,760
-4% -$198K ﹤0.01% 3634
2024
Q1 		$4.8M Sell
113,592
-31,823
-22% -$1.34M ﹤0.01% 3696
2023
Q4 		$6.17M Buy
145,415
+118,696
+444% +$3.41M ﹤0.01% 3359
2023
Q3 		$583K Sell
26,719
-6,934
-21% -$174K ﹤0.01% 7872
2023
Q2 		$1.07M Sell
33,653
-65,627
-66% -$2.01M ﹤0.01% 6525
2023
Q1 		$2.42M Buy
99,280
+76,500
+336% +$2.25M ﹤0.01% 4753
2022
Q4 		$718K Sell
22,780
-35,043
-61% -$989K ﹤0.01% 6961
2022
Q3 		$1.63M Buy
57,823
+50,194
+658% +$1.49M ﹤0.01% 5385
2022
Q2 		$202K Sell
7,629
-26,340
-78% -$748K ﹤0.01% 10615
2022
Q1 		$1.19M Sell
33,969
-46,694
-58% -$1.36M ﹤0.01% 6683
2021
Q4 		$2.62M Buy
80,663
+36,009
+81% +$1.27M ﹤0.01% 4908
2021
Q3 		$1.32M Buy
44,654
+30,092
+207% +$845K ﹤0.01% 6835
2021
Q2 		$373K Sell
14,562
-173,726
-92% -$2.49M ﹤0.01% 10305
2021
Q1 		$2.58M Buy
188,288
+165,788
+737% +$2.43M ﹤0.01% 5307
2020
Q4 		$373K Buy
+22,500
New +$292K ﹤0.01% 8865

Other funds holding CERE

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Susquehanna International Group's CERE Position: Q3 2024 in Review

Susquehanna International Group sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 108,832 shares — an estimated $4.45M sold.

Susquehanna International Group first reported a position in CERE in Q4 2020 and held it in 15 quarters. The position peaked at $6.17M in Q4 2023. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

  • Susquehanna International Group reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Susquehanna International Group sold 108,832 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $4.45M.
  • Susquehanna International Group first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q4 2020 and held it in 15 quarters.
  • Susquehanna International Group's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $6.17M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on Susquehanna International Group's 13F filing for Q3 2024, filed 14 Nov 2024.